In case you missed the live session, the recent webinar, A Post-Election Regulatory Update on 340B is now available to view on-demand.
This webcast, hosted by exclusive 340B Partner, SUNRx, featured special guest speaker, Jeff Davis of Baker Donelson, who covers the latest in 340B regulatory and legislative developments and shares insights on how you can best position your 340B program for success in 2021 and beyond.
Benefit from an overview of 340B including past, present, and future in this webcast that covers:
- How we got here and what you need to know about the lawsuit over drug companies refusing 340B discounts
- How the recent manufacturer actions may impact your 340B program
- What you need to know about new guidance from HHS
- Actions to consider now to position your program for the future
Register now for access to the on-demand webcast!
